Kimberly A. Hoy, JD, CPC, discusses how her session at the 2024 Revenue Integrity Symposium will help organizations fight back against improper Medicare Advantage denials.
The NAHRI Advisory Board plays an instrumental role in the association’s direction and development. Board members donate their invaluable expertise and time to providing insight into the profession and support for NAHRI’s work.
Part A providers and Part B suppliers have until July 12 to apply for Change Healthcare/Optum Payment Disruption (CHOPD) accelerated and advance payments.
CityMD, an urgent care center group, has agreed to pay over $12 million to settle alleged False Claims Act violations related to reimbursement for COVID-19 testing.
Gain deeper insights into where the revenue integrity industry is now, including best practices, staffing and program models, common challenges, and solutions by registering for NAHRI’s free State of the Revenue Integrity Industry webinar on June 5.
CMS recently added two HCPCS codes that organizations can use to bill for PEMGARDA (pemivibart), a monoclonal antibody product for the pre-exposure prophylaxis of COVID-19 in certain adults and adolescents.